HomeAgents Increasing Serum PotassiumAgents Increasing Serum Potassium + Olmesartan Medoxomil And Hydrochlorothiazide

Does Agents Increasing Serum Potassium Interact with Olmesartan Medoxomil And Hydrochlorothiazide?

Agents Increasing Serum Potassium and Olmesartan Medoxomil And Hydrochlorothiazide have a moderate drug interaction according to U.S. FDA drug labeling data. Coadministration may result in hyperkalemia. Monitor serum potassium in patients receiving concomitant potassium-raising agents. The mechanism involves olmesartan medoxomil increases serum potassium; additive effect with other potassium-raising drugs. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Olmesartan Medoxomil And Hydrochlorothiazide Class
Thiazide Diuretic
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Agents Increasing Serum Potassium and Olmesartan Medoxomil And Hydrochlorothiazide occurs because olmesartan medoxomil increases serum potassium; additive effect with other potassium-raising drugs. Clinically, this means coadministration may result in hyperkalemia. monitor serum potassium in patients receiving concomitant potassium-raising agents. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Agents Increasing Serum Potassium and your doctor is considering prescribing Olmesartan Medoxomil And Hydrochlorothiazide (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Agents Increasing Serum Potassium(Imogam)+💊 Olmesartan Medoxomil And Hydrochlorothiazide(Benicar HCT)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Thiazide Diuretic
Source
NLP:olmesartan medoxomil and hydrochlorothiazide

What this means in plain English

Coadministration may result in hyperkalemia. Monitor serum potassium in patients receiving concomitant potassium-raising agents.

About Agents Increasing Serum Potassium and Olmesartan Medoxomil And Hydrochlorothiazide

Olmesartan Medoxomil And Hydrochlorothiazide is a Thiazide Diuretic. You may recognize them by the brand names Imogam and Benicar HCT. Olmesartan Medoxomil And Hydrochlorothiazide is taken by mouth. Olmesartan Medoxomil And Hydrochlorothiazide additionally carries an FDA boxed warning, the FDA's strongest safety alert.

What the FDA label says

"Olmesartan medoxomil increases serum potassium; additive effect with other potassium-raising drugs"

📖 Source: NLP:olmesartan medoxomil and hydrochlorothiazide

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Agents Increasing Serum Potassium and Olmesartan Medoxomil And Hydrochlorothiazide against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.